Epigral Ltd.
NSE: EPIGRAL · Chemicals
Sector
Chemicals
Size band
Small cap
Market cap
4,102cr
P/E
12.1
ROE
22.6%
Dividend yield
0.6%
No price is shown on this page, live or delayed. It records what management said on the earnings call, and the company’s filings.
Measured against
Peer set
Speciality Chemicals · largest 12 of 32 measured at Q1 FY27 · financials via Screener| Company | Operating margin | Revenue growth |
|---|---|---|
| Gujarat Fluorochemicals Ltd. | 27.0% | 24.0% |
| Navin Fluorine International Ltd. | 34.0% | 44.1% |
| Atul Ltd. | 21.0% | 25.0% |
| Aarti Industries Ltd. | 16.0% | 42.5% |
| Aether Industries Ltd. | 31.0% | 27.2% |
| Anupam Rasayan India Ltd. | 25.0% | 34.8% |
| Vinati Organics Ltd. | 24.0% | 28.4% |
| Privi Speciality Chemicals Ltd. | 23.0% | 19.1% |
| Jubilant Ingrevia Ltd. | 15.0% | 25.2% |
| Clean Science And Technology Ltd. | 36.0% | 10.3% |
| Alkyl Amines Chemicals Ltd. | 25.0% | 30.0% |
| Epigral Ltd. | 25.0% | 16.1% |
No guidance on record.
This section quotes what management told the market on the quarterly earnings call. We have not transcribed one for Epigral Ltd..
No broadcast calls recorded.
We log calls made about a company on business television — Zee Business, CNBC Awaaz and NDTV Profit — as they are stated on air. Nothing is on record for Epigral Ltd..
Shareholding
change across 4 filings| Category | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Change |
|---|---|---|---|---|---|
| Promoters | 68.8 | 68.8 | 68.8 | 68.8 | 0.0 |
| Foreign institutions | 1.0 | 1.5 | 2.4 | 2.7 | −1.7 |
| Domestic institutions | 5.6 | 4.9 | 5.1 | 4.9 | +0.7 |
| Retail & others | 24.6 | 24.7 | 23.7 | 23.5 | +1.1 |
As filed with the exchange for the periods ending Sep 25 to Jun 26.
Filings
latest 25 of 250- Epigral Limited has informed the Exchange about Investor / Analyst Plant Visit on Thursday, 03.09.202631 Aug 2026
- Analysts/Institutional Investor Meet/Con. Call Updates31 Aug 2026
- Analysts/Institutional Investor Meet/Con. Call Updates18 Aug 2026
- Analysts/Institutional Investor Meet/Con. Call Updates7 Aug 2026
- Analysts/Institutional Investor Meet/Con. Call Updates30 Jul 2026
- Analysts/Institutional Investor Meet/Con. Call Updates30 Jul 2026
- Copy of Newspaper Publication29 Jul 2026
- Analysts/Institutional Investor Meet/Con. Call Updates27 Jul 2026
- Audio Recording of Conference Call discussing Q1 FY27 Results held on Monday, 27th July, 2026 at 5.00 p.m.27 Jul 2026
- Investor Presentation27 Jul 2026
- Press Release27 Jul 2026
- Adoption of new line(s) of business27 Jul 2026
- Outcome of Board Meeting27 Jul 2026
- Analysts/Institutional Investor Meet/Con. Call Updates22 Jul 2026
- Spurt in Volume22 Jul 2026
- Spurt in Volume21 Jul 2026RoutineGeneral
- Credit Rating- Revision14 Jul 2026
- Certificate under SEBI (Depositories and Participants) Regulations, 20189 Jul 2026
- Epigral Limited has informed the Exchange about Incorporation of a Wholly owned Subsidiary namrly "Epigral Advanced Materials Limited".7 Jul 2026
- General Updates7 Jul 2026
- Disclosure under SEBI Takeover Regulations29 Jun 2026
- Analysts/Institutional Investor Meet/Con. Call Updates10 Jun 2026
- Shareholders meeting9 Jun 2026
- Shareholders meeting8 Jun 2026
- Credit Rating3 Jun 2026
The 25 most recent of 250 filings we hold for EPIGRAL, back to January 2024. Every filing, by day.
Disclaimer
Guidance is quoted from management commentary on quarterly earnings calls; the words are the company's own and the targets are theirs, not ours. Peer comparisons use quarterly financials sourced from Screener, with every company measured at the same fiscal quarter; the peer set is companies sharing the same industry classification, and comparisons are descriptive, not a ranking or a view. Filings are reproduced as companies filed them to the NSE and BSE; Bharatstox does not verify, endorse or comment on their contents. This page is for informational and educational purposes only and does not constitute investment advice, research, or a recommendation to buy or sell any security. Investing in securities markets is subject to market risks. Read all related documents carefully before investing.